Clinical Trials Logo

Filter by:
NCT ID: NCT00534807 Withdrawn - Cancer Clinical Trials

A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced Cancer

Start date: September 2007
Phase: Phase 1
Study type: Interventional

The purpose of this study is to test how vinflunine interacts with rifampin in the human body

NCT ID: NCT00534339 Withdrawn - Morbid Obesity Clinical Trials

EasyBand GOAL Trial

Start date: December 2010
Phase: N/A
Study type: Interventional

Safety, effectiveness, and performance of Allergan's EasyBand telemetrically adjustable gastric banding device for the treatment of morbidly obese patients.

NCT ID: NCT00533741 Withdrawn - Clinical trials for Coronavirus (SARS-CoV)

SARS Coronavirus Vaccine (SARS-CoV)

Start date: n/a
Phase: Phase 1
Study type: Interventional

Severe acute respiratory syndrome (SARS) is a viral illness that affects the respiratory (breathing) system. The purpose of this study is to evaluate the safety and protective (immune) responses to different doses of a SARS vaccine given with or without an adjuvant. An adjuvant is a substance that may be added to a vaccine to improve the immune response so that less of the vaccine may need to be given. Study participants will include 72 volunteers, ages 18-40, living in the Houston, Texas area. The study will take place at Baylor College of Medicine. Participants will receive 2 injections of vaccine or placebo (substance made to look like the study vaccine but contains no medication) given 1 month apart. Participants will fill out a memory aid (diary) to document daily temperature and illness signs and symptoms for 7-9 days after each injection. During the 9 study visits, several blood samples will be collected. Participants will be in the study for up to 211 days, including screening.

NCT ID: NCT00532584 Withdrawn - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

Effect of Steroids on Gene Expression in the Healthy Smokers Lungs

Start date: February 2011
Phase: Phase 4
Study type: Interventional

Cigarette smoking is the main risk factor for chronic obstructive pulmonary disease (COPD). The cells lining the lung airways (epithelium) and the cells on the surface of the epithelium (alveolar macrophages) of healthy smokers develop characteristic gene expression changes that are different from that of nonsmokers. These gene expression changes include up- and down-regulation of genes in functional categories known to be relevant to the development of COPD. Administration of anti-inflammatory medications (inhaled steroids) in combination with long acting medications that open the airways (bronchodilators), are known to decrease the rate of acute exacerbations and improve the quality of life of individuals with COPD; however, the mechanisms underlying these beneficial effects of are poorly understood. This study will assess the effect of traditional therapy for COPD (inhaled corticosteroids, an anti-inflammatory medication, plus a bronchodilator, a medication that helps open the airways) on smoking-induced gene changes in airway epithelium and alveolar macrophages. Volunteer subjects will be evaluated by bronchoscopy to sample lung cells at 0, 7 and 14 days, with the therapy given at day 1 through day 7. The bronchoscopy aspects of this study will be covered by approved Weill-Cornell IRB protocol # 0005004439 (see below.) To participate in this protocol, the research subject will first be enrolled in Weill-IRB protocol #0005004439 entitled "Evaluation of the Lungs of Normal (Smokers, Ex-smokers, Non-Smokers) Individuals with Segmental Bronchopulmonary Lung Lavage, Bronchial Brushing, and Bronchial Wall Biopsy", fulfilling the inclusion/exclusion criteria of that protocol. They will be invited to participate in this protocol only if they meet the additional inclusion/exclusion criteria of this protocol.

NCT ID: NCT00532376 Withdrawn - Depression Clinical Trials

fMRI Investigation of Depression in Patients With Epilepsy

Start date: September 2005
Phase: N/A
Study type: Observational

Depression is very common in epilepsy. Depression is the strongest predictor of poor quality of life in patients with epilepsy. The biological basis for depression in epilepsy remains poorly understood. This study uses functional MRI (fMRI) to examine brain response to emotional and non-emotional stimuli in healthy control subjects and in patients with epilepsy who are either depressed or not depressed. Results from this study will contribute to a better understanding of depression in epilepsy, which may eventually inform development of better treatment modalities..

NCT ID: NCT00531856 Withdrawn - Clinical trials for Kidney Transplantation

Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients

Start date: August 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and tolerability of two carbon monoxide doses when administered as an inhaled gas for 1 hour in patients receiving kidney transplants.

NCT ID: NCT00531349 Withdrawn - Cancer Clinical Trials

Regional Anesthesia and Endometrial Cancer Recurrence

ECA/R
Start date: November 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether recurrence of local and metastatic cancer after open hysterectomy for stage 1 or 2 endometrial cancer is reduced when patients receive epidural anesthesia/analgesia combined with propofol sedation rather than sevoflurane anesthesia and opioid analgesia.

NCT ID: NCT00530751 Withdrawn - Breast Cancer Clinical Trials

Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation

Start date: March 2007
Phase: N/A
Study type: Observational

RATIONALE: Learning about the concerns that individuals may have about providing family medical history online for genetic risk assessment or research may help doctors plan future research. PURPOSE: This clinical trial is studying views on sharing family medical history in healthy women undergoing mammograms or breast evaluation.

NCT ID: NCT00530413 Withdrawn - Epilepsy Clinical Trials

Study of Phenobarbital Inhibition of Catamenial Epilepsy

Start date: March 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to test the effectiveness of low-dose Phenobarbital on the treatment of catamenial epilepsy. We propose that since the catamenial seizures are associated with the reduction in levels of GABA-enhancing allopregnanolone, short-term replacement with the GABAR-enhancing agent Phenobarbital will reduce the incidence of catamenial seizures.

NCT ID: NCT00530205 Withdrawn - Lung Cancer Clinical Trials

Effects of Radiation Therapy on the Body in Patients With Stage III Non-Small Cell Lung Cancer

Start date: February 2007
Phase: N/A
Study type: Observational

RATIONALE: Learning about the effects of radiation therapy on the body's muscles, organs, and bones in patients with stage III non-small cell lung cancer may help doctors plan the best treatment. PURPOSE: This clinical trial is studying the effects of radiation therapy on the body in patients with stage III non-small cell lung cancer.